The Labor Law Insider: Beware the Unfair Labor Practice - Not Just for Unions Anymore
JONES DAY TALKS®: Women in IP: 2020 in Review and a Look Toward 2021
KT Sound Bytes Episode 1 | The Effects of the Supreme Court Decision in Liu v. SEC
JONES DAY PRESENTS®: Trade Secret Enforcement in the United Kingdom
JONES DAY TALKS®: Straight Talk About False Advertising: What Every Lawyer Needs to Know
Bar Exam Toolbox Podcast Episode 86: Tackling a California Bar Exam Essay: Remedies
Episode 5: Business Divorce, Delaware Style
Should Wall Street Fear Mary Jo White?
Critical decisions are pending before courts and legislators in 2023 that promise to shape the future of the 340B Drug Pricing Program (340B Program), which provides discounts on outpatient drugs for certain health care...more
On Friday, July 15th, CMS published its CY 2023 Medicare Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule (Proposed Rule) and gave 340B covered entities a glimpse into how the agency intends to react to...more
Earlier this week, the Supreme Court released its opinion in American Hospital Association et al. v. Becerra et al., a case that involves the proper method for the Medicare program to reimburse hospitals for outpatient drugs...more
Report on Medicare Compliance 29, no. 2 (January 20, 2020) - CMS has agreed to pay a physical therapy practice $55,000 in a December settlement that’s at the intersection of claims and enrollment, and again runs into the...more
In Part Two of this two-part series on recent developments in pharmacy law and the 340B drug pricing program, Richard Church and Ryan Severson discuss several recent developments related to the 340B drug pricing program,...more
This past week, CMS confirmed it will continue the 2018 and 2019 underpayment policy for certain 340B covered entities unless the D.C. Court of Appeals upholds the lower court’s ruling that it is unlawful. In that case, CMS...more
The U.S. government has appealed a federal district court decision issued in December 2018 that found the Department of Health & Human Services (HHS) exceeded its authority by reducing Part B drug reimbursement to certain...more
In an opinion issued December 27, 2018, a Federal District Court ruled that the Department of Health & Human Services (HHS) exceeded its authority by reducing Part B drug reimbursement to certain hospitals in the 340B drug...more